Supply Chain Management White Papers

Economic Benefits of EPC in Pharmaceuticals

Overview The pharmaceutical industry is an area where there is significant activity around EPC and understanding how best to apply the technology to improve efficiency and reduce losses. Cap Gemini Ernst & Young (CGE&Y) in collaboration with the Auto-ID Center has developed a business case for the adoption of Auto-ID in the pharmaceutical industry. This white paper identifies not only the opportunities available within the supply chain, it also includes benefits within the drug development and clinical trials process, as well as improvements to patient safety and effects on gray market activities.

Further White Paper Details
PublisherAuto-ID Center File FormatPDF, requires Acrobat Rdr 5
Date PublishedOctober 2003 Downloads16
FormatWhite Papers   
Topics
Thin clients switch on digitally excluded

Thin clients switch on digitally excluded

Case study: Digital inclusion project tackles social exclusion in Liverpool more

Renault goes multilingual

Renault goes multilingual

Case study: Translation tech turns docs into 23 languages… more


Quick Sitemap Links: